Softwr

Healthcare · head to head

Kareo vs Paige

Kareo logo

Kareo

Healthcare

Cloud-based EHR and billing for small practices

From
$99/month
Rated
-
Paige logo

Paige

Healthcare

Digital pathology AI holding the first FDA De Novo authorisation for a pathology algorithm, now part of Tempus

From
On request
Rated
-

The short version

  • Each has a real cost: Kareo kareo is now part of Tebra and sold under the Tebra brand rather than as a standalone product; Paige the FDA authorisation is confined to prostate core needle biopsies, on compatible scanners, viewed through FullFocus, as an adjunct only; every other tissue type and every grading claim is outside that authorisation in the United States.
  • They diverge on capability: Kareo covers Electronic Health Records, Paige covers Paige Prostate Detect.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Kareo and Paige actually diverge.

Attributes where Kareo and Paige differ
AttributeKareoPaige
Starting price$99/monthOn request
Pricing modelsubscriptionquote
PlatformsWeb, MobileWeb, Cloud, On-premise
Founded2010Unknown

Identical on both: free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Kareo

  • Electronic Health Records
  • Scheduling
  • Patient Portal
  • Medical Billing
  • Payment Processing
  • Labs
  • Pharmacies
  • Clearinghouses

Only in Paige

  • Paige Prostate Detect
  • Paige Prostate Grade and Quantify
  • Perineural invasion detection
  • Breast and lymph node applications
  • FullFocus viewer
  • Foundation models
  • OmniScreen
  • Paige Alba

What people use each for

The jobs each tool is most often brought in to do.

Kareo

  • Practice management, scheduling and billing for independent medical practicesnot Paige
  • Electronic health records and e-prescribing for small clinicsnot Paige
  • Insurance claim submission and patient payment collectionnot Paige

Paige

  • A reference laboratory processing high volumes of prostate core needle biopsies where a second read on every case is not staffablenot Kareo
  • A pathology department already digitised that wants a documented safety net against missed small foci of cancernot Kareo
  • A hospital laboratory struggling to recruit uropathology subspecialists and needing consistency across generalist reportingnot Kareo
  • A pharmaceutical company needing consistent biomarker scoring across trial sites rather than site-by-site pathologist variabilitynot Kareo

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Kareo

  • Kareo is now part of Tebra and sold under the Tebra brand rather than as a standalone product
  • Tebra publishes no rate: pricing varies with provider count, features and implementation requirements and is quoted during a demo
  • Billing counts clinical providers such as MDs, DOs, NPs and PAs, so adding a prescriber raises the bill even though non clinical staff are free
  • Electronic prescribing of controlled substances setup costs about $75 per provider as a one time fee
  • PDMP integration costs $500 one time per facility plus about $50 per user per year

Paige

  • The FDA authorisation is confined to prostate core needle biopsies, on compatible scanners, viewed through FullFocus, as an adjunct only; every other tissue type and every grading claim is outside that authorisation in the United States.
  • The algorithm is worthless without a digital pathology programme already running, and slide scanning, storage and workflow typically cost far more than the software licence.
  • Tempus acquired Paige in 2025, so the roadmap now competes for attention inside a genomics-led business, and the pathology-only buyer is no longer the primary customer.
  • Scanner compatibility is a hard constraint rather than a preference, and a laboratory with an unsupported scanner fleet cannot use the authorised indication at all.
  • Pricing is per case or per slide and unpublished, so a laboratory cannot model cost per reported case without entering a sales process.

Pricing, plan by plan

Kareo

$99/month
  • Starter$99/month
    • EHR
    • Scheduling
    • Patient Portal
  • Professional$199/month
    • Everything in Starter
    • Billing
    • Reporting

Paige

On request
  • Paige clinical applications$undefined/year
    • Priced per case or per slide analysed under annual agreement
    • Prostate, breast and other applications licensed separately
    • Requires compatible whole slide scanner and the FullFocus viewer for the authorised indication

Which should you pick?

Choose Kareo if

  • You need electronic health records.
  • You work on Web, Mobile.
  • You also want scheduling.

Choose Paige if

  • You need paige prostate detect.
  • You work on Web, Cloud, On-premise.
  • You also want paige prostate grade and quantify.

Questions people ask

Is Kareo or Paige better?
Neither clearly leads. Kareo starts at $99/month and Paige at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Kareo or Paige?
Kareo starts at $99/month and Paige at On request.
Does Kareo or Paige run on more platforms?
Kareo runs on Web, Mobile. Paige runs on Web, Cloud, On-premise.
What is Kareo best used for?
Kareo is most often used for practice management, scheduling and billing for independent medical practices, electronic health records and e-prescribing for small clinics, insurance claim submission and patient payment collection. Of those, practice management, scheduling and billing for independent medical practices and electronic health records and e-prescribing for small clinics are not what Paige is typically brought in for.
What can Kareo do that Paige cannot?
Kareo covers Electronic Health Records, Scheduling, Patient Portal, Medical Billing. Paige covers Paige Prostate Detect, Paige Prostate Grade and Quantify, Perineural invasion detection, Breast and lymph node applications.

Answered from the vendors’ own pages

Kareo: Does Kareo publish its pricing?

No. Kareo (now rebranded as Tebra) uses custom per-practice pricing that varies based on the number of providers, features needed, and implementation requirements. Pricing is determined during a demo with the sales team.

Source
Paige: What exactly is FDA authorised?

Paige Prostate Detect, as an adjunct for identifying areas of interest on digitised prostate core needle biopsy slides, viewed through the Paige FullFocus viewer on a compatible scanner. Nothing else in the portfolio holds that authorisation in the United States.

Kareo: Are there discounts for adding multiple modules?

Yes. Tebra states that many practices qualify for bundled pricing or volume incentives when adopting multiple modules like EHR, billing, and patient experience tools together.

Source
Paige: Is the European position broader?

Yes. The Paige Prostate suite including grading and quantification received IVDR certification in 2025, which covers more than the United States authorisation.

Kareo: What are the additional costs for controlled substance prescribing?

For providers who prescribe controlled substances, EPCS setup costs approximately $75 per provider as a one-time fee, and PDMP integration costs $500 one-time per facility plus around $50 per user per year.

Source
Paige: What did the pivotal study measure?

Pathologist cancer detection on individual slide images improved, with reported reductions in false negative and false positive readings. It measured pathologist performance with the tool, not standalone algorithm accuracy.

Kareo: Does Kareo offer a free trial?

Kareo's website does not mention a free trial option. Access to pricing and trial arrangements requires contacting the sales team to request a demo.

Source
Paige: Who owns Paige now?

Tempus AI acquired Paige in 2025. Products remain branded Paige.

Share

Related pages

Other head to heads